Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Federico Comoglio

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Nature Genetics|April 25, 2017
Stable Polycomb-dependent transgenerational inheritance of chromatin states in DrosophilaFilippo Ciabrelli, Federico Comoglio, Simon Fellous, et al.
The Journal of Experimental Medicine|September 14, 2017
Mbd3/NuRD controls lymphoid cell fate and inhibits tumorigenesis by repressing a B cell transcriptional programStephen J Loughran, Federico Comoglio, Fiona K Hamey, et al.
Blood|January 9, 2017
HSP90 promotes Burkitt lymphoma cell survival by maintaining tonic B-cell receptor signalingRoland Walter, Kuan-Ting Pan, Carmen Doebele, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 8, 2016
Elucidation of tonic and activated B-cell receptor signaling in Burkitt's lymphoma provides insights into regulation of cell survivalJasmin Corso, Kuan-Ting Pan, Roland Walter, et al.
Nature Genetics|June 30, 2019
High-throughput identification of human SNPs affecting regulatory element activityJoris van Arensbergen, Ludo Pagie, Vincent D FitzPatrick, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 6, 2020
Rewiring of B cell receptor signaling by Epstein-Barr virus LMP2AKamonwan Fish, Federico Comoglio, Arthur L Shaffer, et al.
Nature Communications|August 4, 2019
Selective inactivation of hypomethylating agents by SAMHD1 provides a rationale for therapeutic stratification in AMLThomas Oellerich, Constanze Schneider, Dominique Thomas, et al.
Leukemia|November 7, 2023
PDP1 is a key metabolic gatekeeper and modulator of drug resistance in FLT3-ITD-positive acute myeloid leukemiaIslam Alshamleh, Nina Kurrle, Philipp Makowka, et al.
Nature Medicine|June 7, 2017
Corrigendum: SAMHD1 is a biomarker for cytarabine response and a therapeutic target in acute myeloid leukemiaConstanze Schneider, Thomas Oellerich, Hanna-Mari Baldauf, et al.
Cancer Cell|April 12, 2017
Hoxa9 and Meis1 Cooperatively Induce Addiction to Syk Signaling by Suppressing miR-146a in Acute Myeloid LeukemiaSebastian Mohr, Carmen Doebele, Federico Comoglio, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Nature Genetics|April 25, 2017
Stable Polycomb-dependent transgenerational inheritance of chromatin states in DrosophilaFilippo Ciabrelli, Federico Comoglio, Simon Fellous, et al.
The Journal of Experimental Medicine|September 14, 2017
Mbd3/NuRD controls lymphoid cell fate and inhibits tumorigenesis by repressing a B cell transcriptional programStephen J Loughran, Federico Comoglio, Fiona K Hamey, et al.
Blood|January 9, 2017
HSP90 promotes Burkitt lymphoma cell survival by maintaining tonic B-cell receptor signalingRoland Walter, Kuan-Ting Pan, Carmen Doebele, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 8, 2016
Elucidation of tonic and activated B-cell receptor signaling in Burkitt's lymphoma provides insights into regulation of cell survivalJasmin Corso, Kuan-Ting Pan, Roland Walter, et al.
Nature Genetics|June 30, 2019
High-throughput identification of human SNPs affecting regulatory element activityJoris van Arensbergen, Ludo Pagie, Vincent D FitzPatrick, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 6, 2020
Rewiring of B cell receptor signaling by Epstein-Barr virus LMP2AKamonwan Fish, Federico Comoglio, Arthur L Shaffer, et al.
Nature Communications|August 4, 2019
Selective inactivation of hypomethylating agents by SAMHD1 provides a rationale for therapeutic stratification in AMLThomas Oellerich, Constanze Schneider, Dominique Thomas, et al.
Leukemia|November 7, 2023
PDP1 is a key metabolic gatekeeper and modulator of drug resistance in FLT3-ITD-positive acute myeloid leukemiaIslam Alshamleh, Nina Kurrle, Philipp Makowka, et al.
Nature Medicine|June 7, 2017
Corrigendum: SAMHD1 is a biomarker for cytarabine response and a therapeutic target in acute myeloid leukemiaConstanze Schneider, Thomas Oellerich, Hanna-Mari Baldauf, et al.
Cancer Cell|April 12, 2017
Hoxa9 and Meis1 Cooperatively Induce Addiction to Syk Signaling by Suppressing miR-146a in Acute Myeloid LeukemiaSebastian Mohr, Carmen Doebele, Federico Comoglio, et al.
Pageof 4